Podcast
Excellence in Healthcare Delivery Across the Lung Cancer Continuum
Season 1: Precision Oncology in NSCLC: HER2 Mutation and Guideline Target Therapies
In this seven-part podcast series, leading experts discuss the role of precision oncology in non-small cell lung cancer, with a focus on HER2 mutations and current guideline-based targeted treatment.
- Episodes
- 1
- Typical length
- 27 min
- On air since
- 2026
- Latest episode
- 5 days ago
Episodes
1 episode, newest first
-
27 min
S1E1: HER2 Series: Understanding NSCLC Histology and Oncogenesis of HER2 (ERBB2) Mutation in NSCLC
Season 1, Episode 1
Show notes
In this episode, Dr. Andrew Ciupek interviews Dr. Courtney Granville about NSCLC histologic subtypes and HER2 alterations, including mutation, amplification, and overexpression, and how HER2-driven signaling pathways promote tumor growth and progression.
Note: this is a companion podcast to the continuing education course in the GO2 for Lung Cancer Global Knowledge Center.
Select the link below to go to the full continuing education course:
Understanding NSCLC Histology and Oncogenesis of HER2 (ERBB2) Mutation in NSCLC
Medicine lists
More Medicine shows picked out from the charts
More in Medicine
Placed highest on Apple Podcasts' Medicine chart right now
